BRPI0509475A - matrizes de hidrogel aniÈnico com liberação modificada dependente do ph como veìculos de fármacos - Google Patents
matrizes de hidrogel aniÈnico com liberação modificada dependente do ph como veìculos de fármacosInfo
- Publication number
- BRPI0509475A BRPI0509475A BRPI0509475-5A BRPI0509475A BRPI0509475A BR PI0509475 A BRPI0509475 A BR PI0509475A BR PI0509475 A BRPI0509475 A BR PI0509475A BR PI0509475 A BRPI0509475 A BR PI0509475A
- Authority
- BR
- Brazil
- Prior art keywords
- modified release
- drug carriers
- hydrogel matrices
- anionic hydrogel
- dependent modified
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
MATRIZES DE HIDROGEL ANIÈNICO COM LIBERAçãO MODIFICADA DEPENDENTE DO PH COMO VEìCULOS DE FáRMACOS. A presente invenção refere-se a composições com liberação modificada dependente do pH que são descritas, consistindo em matrizes de hidrogel contendo um ou mais ingredientes ativos, nas quais as matrizes referidas são adequadas para liberar os ingredientes ativos referidos em uma maneira prolongada em dados sítios do como.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000168A ITRM20040168A1 (it) | 2004-04-01 | 2004-04-01 | Composizione a rilascio modificato ph dipendente. |
PCT/IT2005/000081 WO2005094792A1 (en) | 2004-04-01 | 2005-02-16 | Anionic hydrogel matrices with ph dependent modified release as drug carriers |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0509475A true BRPI0509475A (pt) | 2007-09-11 |
Family
ID=34961555
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0509475-5A BRPI0509475A (pt) | 2004-04-01 | 2005-02-16 | matrizes de hidrogel aniÈnico com liberação modificada dependente do ph como veìculos de fármacos |
Country Status (20)
Country | Link |
---|---|
US (1) | US20070166383A1 (pt) |
EP (1) | EP1729732B1 (pt) |
JP (1) | JP2007530666A (pt) |
KR (1) | KR20060133578A (pt) |
CN (1) | CN1913875B (pt) |
AT (1) | ATE428405T1 (pt) |
AU (1) | AU2005228716B2 (pt) |
BR (1) | BRPI0509475A (pt) |
CA (1) | CA2551797A1 (pt) |
CY (1) | CY1109209T1 (pt) |
DE (1) | DE602005013935D1 (pt) |
DK (1) | DK1729732T3 (pt) |
ES (1) | ES2325626T3 (pt) |
HR (1) | HRP20090329T1 (pt) |
IT (1) | ITRM20040168A1 (pt) |
PL (1) | PL1729732T3 (pt) |
PT (1) | PT1729732E (pt) |
RS (1) | RS51178B (pt) |
SI (1) | SI1729732T1 (pt) |
WO (1) | WO2005094792A1 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4746883B2 (ja) * | 2005-01-28 | 2011-08-10 | リンテック株式会社 | ハイドロゲル基剤、パップ剤基剤、パップ剤及び水性ゲルシート |
EP2379226B1 (en) | 2008-12-31 | 2016-04-20 | 3M Innovative Properties Company | Live bioload detection using microparticles |
JP2012513768A (ja) | 2008-12-31 | 2012-06-21 | スリーエム イノベイティブ プロパティズ カンパニー | サンプリング装置及び微生物を濃縮するための方法 |
US9284593B2 (en) | 2009-12-30 | 2016-03-15 | 3M Innovative Properties Company | Live bioload detection using microparticles |
US8845801B2 (en) | 2009-12-30 | 2014-09-30 | Regents Of The University Of Minnesota | Bone cement and method |
KR101228106B1 (ko) * | 2010-01-21 | 2013-02-01 | 광주과학기술원 | 피부투과도, 세포유입 및 종양전달성이 증가된 나노운반체 |
WO2011090349A2 (ko) * | 2010-01-21 | 2011-07-28 | 광주과학기술원 | 피부투과도, 세포유입 및 종양전달성이 증가된 나노운반체 |
CN103330702B (zh) * | 2013-07-02 | 2016-03-02 | 江苏长泰药业有限公司 | 含有拟交感神经胺盐和诱导凝胶体系的医药组合物 |
CN108452291A (zh) * | 2018-07-04 | 2018-08-28 | 西南大学 | 用天然丝胶蛋白治疗溃疡性结肠炎的方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4071508A (en) * | 1975-02-11 | 1978-01-31 | Plastomedical Sciences, Inc. | Anionic hydrogels based on hydroxyalkyl acrylates and methacrylates |
IT1284661B1 (it) * | 1996-06-06 | 1998-05-21 | Sigma Tau Ind Farmaceuti | Uso di alcanoil l-carnitine nel trattamento terapeutico di malattie infiammatorie croniche intestinali. |
DE19653631A1 (de) * | 1996-12-20 | 1998-06-25 | Basf Coatings Ag | Verfahren zum Herstellen von durch Strahlung vernetzbaren polymeren Acryl- oder Methacrylsäureestern |
PT986408E (pt) * | 1997-06-03 | 2005-09-30 | Innogenetics Nv | Novos medicamentos baseados em polimeros compostos por gelatina modificada com metacrilamida |
DE60021059T2 (de) * | 1999-02-03 | 2006-05-18 | Powderject Research Ltd. | Partikuläre pharmazeutische Zusammensetzung für eine transdermale Partikelabgabe aus einem nadellosen Spritzensystem |
US6547182B2 (en) * | 2001-07-19 | 2003-04-15 | Aerojet-General Corporation | Solid rocket motor bolted thrust takeout structure |
US7204997B2 (en) * | 2002-01-29 | 2007-04-17 | Supratek Pharma Inc. | Responsive microgel and methods related thereto |
-
2004
- 2004-04-01 IT IT000168A patent/ITRM20040168A1/it unknown
-
2005
- 2005-02-16 AU AU2005228716A patent/AU2005228716B2/en not_active Ceased
- 2005-02-16 PL PL05718991T patent/PL1729732T3/pl unknown
- 2005-02-16 ES ES05718991T patent/ES2325626T3/es active Active
- 2005-02-16 CA CA002551797A patent/CA2551797A1/en not_active Abandoned
- 2005-02-16 BR BRPI0509475-5A patent/BRPI0509475A/pt not_active IP Right Cessation
- 2005-02-16 WO PCT/IT2005/000081 patent/WO2005094792A1/en active Application Filing
- 2005-02-16 AT AT05718991T patent/ATE428405T1/de active
- 2005-02-16 CN CN2005800036356A patent/CN1913875B/zh not_active Expired - Fee Related
- 2005-02-16 DK DK05718991T patent/DK1729732T3/da active
- 2005-02-16 EP EP05718991A patent/EP1729732B1/en active Active
- 2005-02-16 PT PT05718991T patent/PT1729732E/pt unknown
- 2005-02-16 SI SI200530711T patent/SI1729732T1/sl unknown
- 2005-02-16 US US10/596,267 patent/US20070166383A1/en not_active Abandoned
- 2005-02-16 JP JP2007505744A patent/JP2007530666A/ja active Pending
- 2005-02-16 DE DE602005013935T patent/DE602005013935D1/de active Active
- 2005-02-16 RS RSP-2009/0315A patent/RS51178B/sr unknown
- 2005-02-16 KR KR1020067016168A patent/KR20060133578A/ko not_active Application Discontinuation
-
2009
- 2009-06-03 HR HR20090329T patent/HRP20090329T1/xx unknown
- 2009-07-03 CY CY20091100701T patent/CY1109209T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
ATE428405T1 (de) | 2009-05-15 |
AU2005228716A1 (en) | 2005-10-13 |
RS51178B (sr) | 2010-10-31 |
PL1729732T3 (pl) | 2009-09-30 |
EP1729732A1 (en) | 2006-12-13 |
SI1729732T1 (sl) | 2009-08-31 |
DE602005013935D1 (de) | 2009-05-28 |
JP2007530666A (ja) | 2007-11-01 |
EP1729732B1 (en) | 2009-04-15 |
PT1729732E (pt) | 2009-07-02 |
CA2551797A1 (en) | 2005-10-13 |
CY1109209T1 (el) | 2014-07-02 |
AU2005228716B2 (en) | 2010-07-15 |
KR20060133578A (ko) | 2006-12-26 |
US20070166383A1 (en) | 2007-07-19 |
CN1913875A (zh) | 2007-02-14 |
HRP20090329T1 (en) | 2009-09-30 |
ES2325626T3 (es) | 2009-09-10 |
DK1729732T3 (da) | 2009-08-10 |
CN1913875B (zh) | 2011-08-31 |
WO2005094792A1 (en) | 2005-10-13 |
ITRM20040168A1 (it) | 2004-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20090329T1 (en) | Anionic hydrogel matrices with ph dependent modified release as drug carriers | |
DOP2006000179A (es) | 7-aza-indazoles sustituidos, composiciones que les contienen, procedimiento de fabricación y utilización | |
TR201911270T4 (tr) | Polimerik mirsen bileşimleri. | |
BRPI0518869A2 (pt) | agentes citotàxicos compreendendo taxanos | |
UY30816A1 (es) | Compuestos activos en proteina quinasa, composicionesconteniéndolos y plicaciones | |
DK1799748T3 (da) | Bionedbrydelige kationiske polymerer | |
BRPI0516857A (pt) | dispositivos biomédicos que contêm copolìmeros de bloco anfifìlico | |
TW200800967A (en) | Benzimidazole thiophene compounds | |
ECSP045392A (es) | Moduladores tetrahidropiranil-ciclopentil-tetrahidropiridopiridinicos de la actividad de receptores de quimiocina | |
WO2008066630A3 (en) | Methods for reprogramming adult somatic cells and uses thereof | |
TW200613003A (en) | Active compound-containing solid moulded bodies for external use against parasites on animals | |
FR2894143B1 (fr) | Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation. | |
AR048672A1 (es) | Tabletas de desintegracion que comprenden licarbazepina | |
BRPI0507664A (pt) | compostos com atividade antitumor | |
UY28812A1 (es) | Agente parasiticida | |
BRPI0509165A (pt) | composições de liberação prolongada compreendendo torasemida e um polìmero formador de matriz | |
BRPI0510407A (pt) | derivados de 3-amino-2-fenilpirrolidina | |
MA32803B1 (fr) | Utilisation de 7-chloro-n,n,5-triméthyl-4-oxo-3-phényl-3,5-dihydro-4h- pyridazino[4,5-b]indole-1-acétamide en tant que marqueur biologique de niveaux de récepteur périphérique des benzodiazépine | |
TNSN07438A1 (en) | Prolonged release formulation of active principles having a ph-dependent solubility | |
TW200610526A (en) | Novel hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents | |
UA93679C2 (en) | Compounds modulating c-kit and c-fms activity and uses therefor | |
EA201101113A1 (ru) | Пестицидные комбинации | |
ES2422680T3 (es) | Composición fungicida agrícola u hortícola y su uso para el control de fitopatógenos | |
GT200000008A (es) | Pirazolalquilamidas | |
CR10428A (es) | 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzotiazepinas, su preparacion, composiciones que las contienen y utilizacion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2204 DE 02/04/2013. |